Representative Literature References

Click a row to open its literature reference.

Product

Separation Mode

Broad Sample Type

Specific Sample

Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 Next View All

Year

Product

Sep. Mode

Broad Sample Category

Specific Sample

Title

2022	SRT-10C SEC-300	239300-30030	SEC	Antibody	mAb	Development of a robust and semi-automated two-step antibody purification process Mabs. Vol. 13. No. 1. Taylor & Francis, 2021.
2022	BR-C18	102185-4625	RP	Small Molecule	paclitaxel (PTX)	Gelatin Coating for the Improvement of Stability and Cell Uptake of Hydrophobic Drug-Containing Liposomes Molecules 27.3 (2022): 1041.
2022	SRT SEC-1000	215950P-4630	SEC	VLP/Virus/Vaccine	AAV	Impact of Time Out of Intended Storage and Freeze-thaw Rates on the Stability of Adeno-associated Virus 8 and 9 Journal of Pharmaceutical Sciences. January 06, 2022DOI:https://doi.org/10.1016/j.xphs.2022.01.002
2022	SRT SEC-2000	215980P-4630	SEC	DNA/RNA/OLIGO	circ-arRNA	Engineered circular ADAR-recruiting RNAs increase the efficiency and fidelity of RNA editing in vitro and in vivo Nature Biotechnology (2022): 1-10.
2021	Proteomix RP-1000	465950-2105	RP	ADC	Cysteine ADC based on IgG1	In-situ Reverse Phased HPLC Analysis of Intact Antibody-Drug Conjugates
2021	SRT SEC-500	215500-4630	SEC	Antibody	IgG	Comparative Analysis of Antibodies and Heavily Glycosylated Macromolecular Immune Complexes by Size-Exclusion Chromatography Multi-Angle Light Scattering, Native Charge Detection Mass Spectrometry, and Mass Photometry Analytical Chemistry (2021).
2021	Zenix-C and Proteomix HIC butyl-NP5	233300-7830 &, 431NP5-4603	SEC	VLP/Virus/Vaccine	mAbs - SARS-CoV-2	Rapid Identification of Neutralizing Antibodies against SARS-CoV-2 Variants by mRNA Display Cell Reports (2022): 110348.
2021	SRT SEC-2000	215980P-4630	SEC	DNA/RNA/OLIGO	circRNA	RNA circles with minimized immunogenicity as potent PKR inhibitors Molecular Cell (2021)
2021	Zenix SEC-300	213300-4615	SEC	DNA/RNA/OLIGO	mRNA-LNP (Lipid Nanoparticle)	A novel mechanism for the loss of mRNA activity in lipid nanoparticle delivery systems Nature communications 12.1 (2021): 1-11.
2021	SRT SEC-300, SRT SEC-500, SRT SEC-1000	215500-7830, 215500-7805, 215300-7830, 215300-7805, 215950-7830, 215950-7805	SEC	VLP/Virus/Vaccine	AAV	Size Exclusion Chromatography with Dual Wavelength Detection as a Sensitive and Accurate Method for Determining the Empty and Full Capsids of Recombinant Adeno-Associated Viral Vectors Hum Gene Ther . 2021 Aug 27. doi: 10.1089/hum.2021.123.

Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 Next View All

Products | Privacy Policy | Career | Contact Us

By Separation Mode	By Brand	By Sample Based Application
Size Exclusion Ion Exchange Hydrophobic Interaction Ion Exclusion Sub-2 UHPLC Purification Reversed Phase Mixed-mode Phase HILIC View All	SEC-MALS Unix / Unix-C Zenix / Zenix-C SRT / SRT-C SRT-10 / SRT-10C Proteomix HIC / IEX Antibodix Carbomix Proteomix RP View All	ADC Antibody Biosimilar Carbohydrate Cell Lysate DNA/RNA Fusion Protein Glycan Glycoprotein Heparin	Insulin Membrane Protein Organic Acid PEG/PEGylated Protein Peptide Polymer Protein Vaccine/VLP Others